Boardroom Alpha
Boardroom Alpha
PLD · Current Report (Form 8-K) · Filed July 1, 2026

Prologis Inc — Current Report (Form 8-K)

Form
8-K
Filed
July 1, 2026
Period
Jun 29, 2026
Ticker
PLD
Accession
0001193125-26-291634
Boardroom Alpha · Filing insights

Prologis appoints Alfred F. Kelly, Jr. as independent director, joining the Board Governance and Nomination Committee.

About Prologis Inc
Market cap
$131.3B
1Y TSR
+35.1%
3Y TSR
+8.2%
Board grade
B
Sector
Real Estate
CEO
Daniel Letter
Last annual meeting: Apr 28, 2026 · View full Prologis Inc profile →
8-K
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 29, 2026
 
 
PROLOGIS, INC.
PROLOGIS, L.P.
(Exact name of registrant as specified in charter)
 
 
LOGO
 
Maryland (Prologis, Inc.)
Delaware (Prologis, L.P.)
 
001-13545
(Prologis, Inc.)
001-14245
(Prologis, L.P.)
 
94-3281941
(Prologis, Inc.)
94-3285362
(Prologis, L.P.)
(State or other jurisdiction
of Incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
 
Pier 1, Bay 1, San Francisco, California
 
94111
(Address of Principal Executive Offices)
 
(Zip Code)
Registrants’ Telephone Number, including Area Code: (415) 394-9000
N/A
(Former name or former address, if changed since last report.)
 
 
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
 
   
Title of Each Class
 
Trading
Symbol(s)
 
Name of Each Exchange
on Which Registered
Prologis, Inc.   Common Stock, $0.01 par value   PLD   New York Stock Exchange
Prologis, L.P.   2.250% Notes due 2029   PLD/29   New York Stock Exchange
Prologis, L.P.   5.625% Notes due 2040   PLD/40   New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 

Item 5.02.
Departure of Directors or Certain Officers; Election of
Directors
; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 29, 2026, the board of directors (the “Board”) of Prologis, Inc. (“Prologis”) appointed Alfred F. Kelly, Jr. to serve as a director. The Board determined that Mr. Kelly is independent in accordance with applicable New York Stock Exchange and Securities and Exchange Commission rules and regulations. Mr. Kelly is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation
S-K,
and there are no arrangements or understandings between Mr. Kelly and any other person pursuant to which he was selected as a director. Mr. Kelly will join the Board Governance and Nomination Committee. He will receive compensation under Prologis’
non-employee
director compensation program, as described in the section titled “Director Compensation” in Prologis’ definitive proxy statement for its 2026 Annual Meeting of Stockholders, filed on March 19, 2026, which description is incorporated by reference herein.
A copy of the press release announcing the appointment of Mr. Kelly to the Board is attached as Exhibit 99.1 hereto and is incorporated by reference herein.
 
Item 9.01.
Financial Statements and
Exhibits
.
 
(d)
Exhibits
 
Exhibit No.   
Description
 99.1    Press Release, dated July 1, 2026
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrants have duly caused this report to be signed on their behalf by the undersigned hereunto duly authorized.
 
    PROLOGIS, INC.
Date: July 1, 2026     By:   /s/ Deborah K. Briones
    Name:   Deborah K. Briones
    Title:   Chief Legal Officer and General Counsel
    PROLOGIS, L.P.
   
By: Prologis, Inc.,
its General Partner
    By:   /s/ Deborah K. Briones
Date: July 1, 2026     Name:   Deborah K. Briones
    Title:   Chief Legal Officer and General Counsel
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Prologis Inc (PLD)

Reference

Frequently asked questions

When did Prologis Inc file this 8-K?
Prologis Inc (PLD) filed this Current Report (Form 8-K) with the SEC on July 1, 2026. The accession number assigned by EDGAR is 0001193125-26-291634.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Prologis appoints Alfred F. Kelly, Jr. as independent director, joining the Board Governance and Nomination Committee. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Prologis Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Prologis Inc has filed under CIK 1045609, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer